With the world pivoting towards artificial intelligence, savvy investors are on the lookout for the most promising semiconductor stocks for AI. Semiconductors are the essential components in microchips and are critical for AI expansion. They’re driving innovations in AI algorithms and facilitating machine learning models to tackle more complex tasks faster than ever before. With
0 Comments
Investors wanting to enjoy steady and consistent income should consider dividend aristocrats. In fact, even in these chaotic times, dividend investing will ensure that your money continues to grow, no matter what. With economic worries and the stock market subject to volatility, it could be a wise move to invest in these three dividend aristocrats
0 Comments
The 5G market is booming. In fact, according to Statista, global 5G subscriptions are expected to more than double and pass a billion this year alone.  Gartner (NYSE:IT) says 5G infrastructure spending could increase about 22% this year to more than $23 billion globally. According to ReportLinker, the 5G infrastructure market could be worth $231.4 billion
0 Comments
Source: Robert Way / Shutterstock.com Nio (NYSE:NIO) is facing rapidly increasing competition. Meanwhile, the company’s margins are also being pressured by an accelerating price war in the Chinese electric vehicle (EV) market. But that’s not all. Nio’s addressable market is quite limited and the firm lacks strong competitive advantages. Given all of these points, I
0 Comments
A Security Solutions Maker With Market Buzz and a Beverage Company With Momentum. Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
Stereotypically, the concept of bidding up publicly traded enterprises based on their environmental, social, and governance scores – the so-called ESG stocks – might seem an extremely risky proposition. That’s because we have this idea that doing good involves sacrificing capitalistic intent like achieving profitability. To some extent, it’s a reasonable assumption. After all, true
0 Comments
The tech space is littered with casualties of the post-pandemic consolidation, but careful investors can pick through the rubble to get some of the best long-term tech stocks at reasonable prices. The industry tends to come with higher-than-normal valuations, because investors expect exponential growth. It’s a rapidly changing landscape, and companies that ride the wave of the
0 Comments
Loyal investors of electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) have already been through the wringer. Yet, it’s probably only going to get worse for LCID stock. As we’ll see, May 8 will be an important, and possibly terrible, day for Lucid Group and its stakeholders. Moreover, competition from the likes of Tesla (NASDAQ:TSLA) will only
0 Comments
Low-priced stocks are attractive in the sense that it allows investors to build a diversified portfolio even with a small capital. It’s also untrue that low price stocks are purely speculative. With careful screening, investors can find dozens of stocks under $10 with sound fundamentals. An added attraction is when low-priced stocks represent companies that
0 Comments
Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body.  It promises to revolutionize healthcare making stocks in companies offering this form of medicine very intriguing.  The potential return on such shares is clearly high: Developing these treatments requires massive investments
0 Comments
Investors have shown keen interest in biotech after Johnson & Johnson’s (NYSE:JNJ) impressive earnings beat that topped Wall Street’s expectations. The earnings beat reignited enthusiasm for biotech stocks, prompting investors to search for the next big players. The pharmaceutical giant’s adjusted earnings and revenue beat expectations, with strength reported in units including pharmaceuticals. J&J also
0 Comments